| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.991 | 12.193 | 24.688 | 47.375 | 56.179 | 87.083 | 79.280 | 18.984 | 0 | 0 |
| Total Income - EUR | 1.991 | 12.193 | 24.688 | 47.375 | 56.179 | 87.083 | 79.280 | 18.984 | 8.087 | 0 |
| Total Expenses - EUR | 8.990 | 18.429 | 27.834 | 43.776 | 52.348 | 81.498 | 76.650 | 21.587 | 1.003 | 551 |
| Gross Profit/Loss - EUR | -7.000 | -6.236 | -3.146 | 3.599 | 3.830 | 5.586 | 2.630 | -2.603 | 7.084 | -551 |
| Net Profit/Loss - EUR | -7.060 | -6.601 | -4.315 | 2.178 | 2.145 | 4.396 | 1.837 | -3.172 | 7.084 | -551 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Edramed Line Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.374 | 5.607 | 3.858 | 2.164 | 531 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.364 | 6.571 | 8.210 | 11.260 | 11.030 | 19.938 | 26.072 | 12.941 | 10.732 | 9.824 |
| Inventories | 46 | 102 | 294 | 396 | 775 | 1.192 | 1.158 | 1.158 | 1.155 | 1.149 |
| Receivables | 1.657 | 2.948 | 3.308 | 4.300 | 6.397 | 7.537 | 8.883 | 3.930 | 3.519 | 3.591 |
| Cash | 660 | 3.521 | 4.608 | 6.565 | 3.858 | 11.209 | 16.032 | 7.853 | 6.058 | 5.084 |
| Shareholders Funds | -6.970 | -13.500 | -17.587 | -15.086 | -12.649 | -8.013 | -5.999 | -9.190 | -2.078 | -2.617 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 16.794 | 25.760 | 29.718 | 28.566 | 24.210 | 27.951 | 32.071 | 22.131 | 12.809 | 12.441 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Edramed Line Srl